Literature DB >> 29304209

Tolerability profile of the current antifungal armoury.

Ahmad Mourad1, John R Perfect1.   

Abstract

The tolerability of available antifungal agents is essential to the final outcome of the management of invasive mycoses. There are limited classes of antifungal agents for use, and they can have serious direct toxicities and/or drug-drug interactions. In this review, we examine the common toxicities noted for antifungal agents and attempt to both identify the issues around the adverse events and provide clinical context for their occurrence in these fragile patients.
© The Author 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29304209      PMCID： PMC6636388          DOI： 10.1093/jac/dkx446

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  10 in total

1.  Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity.

Authors:  Kevin J Downes; Jennifer L Goldman
Journal:  Clin Pharmacol Ther       Date:  2021-02-27       Impact factor: 6.875

2.  Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.

Authors:  Stefan Schwartz; Oliver A Cornely; Kamal Hamed; Francisco M Marty; Johan Maertens; Galia Rahav; Raoul Herbrecht; Werner J Heinz
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

3.  Population differentiation, antifungal susceptibility, and host range of Trichophyton mentagrophytes isolates causing recalcitrant infections in humans and animals.

Authors:  Sebastian Gnat; Dominik Łagowski; Aneta Nowakiewicz; Marcelina Osińska; Łukasz Kopiński
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-30       Impact factor: 3.267

4.  Design, Synthesis and Antifungal Evaluation of Novel Pyrylium Salt In Vitro and In Vivo.

Authors:  Yue Zhang; Qiuhao Li; Wen Chao; Yulin Qin; Jiayan Chen; Yingwen Wang; Runhui Liu; Quanzhen Lv; Jinxin Wang
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 5.  Investigational Agents for the Treatment of Resistant Yeasts and Molds.

Authors:  Garret T Seiler; Luis Ostrosky-Zeichner
Journal:  Curr Fungal Infect Rep       Date:  2021-05-28

6.  Dectin-1 Promotes Type I and III Interferon Expression to Support Optimal Antifungal Immunity in the Lung.

Authors:  Orchi Dutta; Vanessa Espinosa; Keyi Wang; Samantha Avina; Amariliz Rivera
Journal:  Front Cell Infect Microbiol       Date:  2020-07-08       Impact factor: 5.293

7.  Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus.

Authors:  Mohanad Al-Obaidi; Pamela Younes; Luis Ostrosky-Zeichner
Journal:  Oxf Med Case Reports       Date:  2018-09-18

Review 8.  Invasive Candidiasis in the Elderly: Considerations for Drug Therapy.

Authors:  B G J Dekkers; A Veringa; D J E Marriott; J M Boonstra; K C M van der Elst; F F Doukas; A J McLachlan; Jan-Willem C Alffenaar
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

9.  Amino acid permeases in Cryptococcus neoformans are required for high temperature growth and virulence; and are regulated by Ras signaling.

Authors:  Crislaine Lambiase Calvete; Kevin Felipe Martho; Gabrielle Felizardo; Alexandre Paes; João Miguel Nunes; Camila Oliveira Ferreira; Marcelo A Vallim; Renata C Pascon
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

10.  Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis.

Authors:  Rita Murri; Sara Lardo; Alessio De Luca; Brunella Posteraro; Riccardo Torelli; Giulia De Angelis; Francesca Giovannenze; Francesco Taccari; Lucia Pavan; Lucia Parroni; Maurizio Sanguinetti; Massimo Fantoni
Journal:  Medicina (Kaunas)       Date:  2021-06-26       Impact factor: 2.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.